Eventide Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History
Eventide Asset Management, LLC
- $5.26 Billion
- Q2 2025
A detailed history of Eventide Asset Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,641,401 shares of COLL stock, worth $100 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
2,641,401
Previous 2,639,547
0.07%
Holding current value
$100 Million
Previous $78.8 Million
0.87%
% of portfolio
1.49%
Previous 1.67%
Shares
13 transactions
Others Institutions Holding COLL
# of Institutions
240Shares Held
36.3MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$219 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$120 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$85.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$60 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.52MShares$57.6 Million0.06% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.29B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...